Skip to main content

Table 6 The arms expected to perform better than the control, represented by the shaded region. The best arm(s) is in underlined

From: Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials

Effect

d = 1

Control

d = 2

2.60

d = 3

4.17

d = 4

5.40

d = 5

5.92

d = 6

6.20

d = 7

7.76

d = 8

9.52

Large

0.40

0.59

0.60

0.61

0.62

0.63

0.64

0.65

NBH

0.40

0.40

0.40

0.70

0.40

0.70

0.70

0.70

Over Dose

0.40

0.40

0.50

0.55

0.70

0.40

0.35

0.30